{"organizations": [], "uuid": "9bdbea41d531461ec4cbf3262c1b71ba2bce9d13", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-t2-biosystems-says-total-q4-revenu/brief-t2-biosystems-says-total-q4-revenue-is-expected-to-exceed-previously-guided-range-of-1-1-mln-to-1-3-mln-idUSASB0BZTK", "country": "US", "domain_rank": 408, "title": "BRIEF-T2 Biosystems Says ‍Total Q4 Revenue Is Expected To Exceed Previously Guided Range Of $1.1 Mln To $1.3 Mln​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-04T23:46:00.000+02:00", "replies_count": 0, "uuid": "9bdbea41d531461ec4cbf3262c1b71ba2bce9d13"}, "author": "", "url": "https://www.reuters.com/article/brief-t2-biosystems-says-total-q4-revenu/brief-t2-biosystems-says-total-q4-revenue-is-expected-to-exceed-previously-guided-range-of-1-1-mln-to-1-3-mln-idUSASB0BZTK", "ord_in_thread": 0, "title": "BRIEF-T2 Biosystems Says ‍Total Q4 Revenue Is Expected To Exceed Previously Guided Range Of $1.1 Mln To $1.3 Mln​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-t2 biosystems", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "mln​ reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "biosystems inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "#Market News January 4, 2018 / 9:47 PM / Updated 26 minutes ago BRIEF-T2 Biosystems Says ‍Total Q4 Revenue Is Expected To Exceed Previously Guided Range Of $1.1 Mln To $1.3 Mln​ Reuters Staff \nJan 4 (Reuters) - T2 Biosystems Inc: \n* T2 BIOSYSTEMS ANNOUNCES PRELIMINARY FOURTH QUARTER 2017 FINANCIAL RESULTS AND PROVIDES UPDATE ON T2BACTERIA PANEL \n* - ‍FDA CLEARANCE OF T2BACTERIA PANEL REMAINS ON TRACK FOR Q1 2018​ \n* ‍TOTAL REVENUE IN Q4 IS EXPECTED TO EXCEED PREVIOUSLY GUIDED RANGE OF $1.1 TO $1.3 MILLION​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-04T23:46:00.000+02:00", "crawled": "2018-01-05T00:04:22.002+02:00", "highlightTitle": ""}